Spots Global Cancer Trial Database for PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
Official Title: Asian, International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tamoxifen With or Without Palbociclib ± Goserelin in Women With Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Study ID: NCT03423199
Conditions
Study Description
Brief Summary: This study is conducted to evaluate the benefit of adding palbociclib in hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer patients, regardless of menopausal status, treated with tamoxifen (with or without goserelin) versus tamoxifen alone (with or without goserelin).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Aichi Cancer Center Hospital, Nagoya, Aichi, Japan
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan
Hyogo Cancer Center, Akashi, Hyogo, Japan
Kanagawa Cancer Center, Yokohama, Kanagawa, Japan
Kindai University Hospital, Ōsaka-sayama, Osaka, Japan
Toranomon Hospital, Minato-Ku, Tokyo, Japan
Chiba Cancer Center, Chiba, , Japan
Kyusyu Cancer Center, Fukuoka, , Japan
National Hospital Organization Osaka National Hospital, Osaka, , Japan
National Cancer Center Hospital, Tokyo, , Japan
National Cancer Center, Gyeonggi-do, , Korea, Republic of
Ajou University Hospital, Gyeonggi-do, , Korea, Republic of
Seoul National University Bundang Hospital, Gyeonggi-do, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Severance Hospital, Yonsei University Health System, Soeul, , Korea, Republic of
National University Hospital, Singapore, , Singapore
National Cancer Centre Singapore, Singapore, , Singapore
National Taiwan University Hospital, Taipei, , Taiwan
Taipei Vetarans General Hospital, Taipei, , Taiwan
Sun Yat-Sen Cancer Center, Taipei, , Taiwan
Contact Details
Name: Kan Yonemori, MD, PhD
Affiliation: Department of Breast and Medical Oncology, National Cancer Center Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
